AAS
SRNE

Avantax Advisory Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Avantax Advisory Services’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-81,453
Closed -$907K – 1388
2020
Q3 		$907K Buy
+81,453
New +$907K 0.01% 563